China health sector sees better sentiment from anti-graft drive – execs

Business activities in China's healthcare sector are returning from a sudden near freeze that began in July when Beijing kicked off a year-long anti-corruption campaign, two foreign industry executives said. The campaign targets the bribing of doctors in drug and medical equipment sales and marks a sharp escalation of an anti-corruption drive in the sector that started years ago. "We see a recovery in terms of engagements … we see an improvement in that area," Zafer Unluer, China president of U.S. healthcare company Organon, told Reuters on the sidelines of an industry event in Shanghai.